Nucleate Denmark
Empowering the next generation of biotech leaders in Denmark
Nucleate Denmark brings together the strength of the three nonprofit organizations, Synapse – Life Science Connect, REBBLS and Nucleate, to bring Nucleate’s Activator Program to Denmark.
In 2019, Nucleate was founded with a vision to bridge the gap between the diverse talent pools at Harvard and beyond—PhDs,post-docs, MBAs, and medical students. The goal was not only to foster a vibrant community where new projects, ideas, and companies could thrive, but also to make the intimidating world of biotech entrepreneurship more accessible.
To date, more than 255 teams across Nucleate’s 24 core chapters (in 6 countries) have gone through The Activator. This makes it the largest trainee-led global biotech accelerator by number of participating teams. Pioneering technologies joining Nucleate range from therapeutics and diagnostics to biomanufacturing and food & agriculture. As of June 2024, Activator alumni teams and participants from the 2019-2023 cohort have raised a cumulative amount of +$370m, creating more than 100 companies , offering over 200 jobs and 1 FDA approval.
The Activator Program
The Nucleate Activator Program is collaboratively designed with world-class advisors featuring a comprehensive curriculum that includes interdisciplinary team-formation, mentor-matching, and bi-weekly workshops over the course of five months, addressing critical aspects of early-stage life science company formation. The Program identifies promising future bio-entrepreneurs working on impactful research and facilitates the formation of new life science companies. Unlike traditional accelerators, this program offers an equity-free, cost-free, hands-on entrepreneurship program that stimulates innovation both within and across regional ecosystems.
You can apply to the Activator program here.
